Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Obsessive-Compulsive Disorder

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Obsessive-Compulsive Disorder in 2 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zohar, J1
Kindler, S1
Murphy, DL1

Trials

1 trial available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Obsessive-Compulsive Disorder

ArticleYear
Update of the serotonergic hypothesis of obsessive compulsive disorder.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Receptors, N-Met

1992

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Obsessive-Compulsive Disorder

ArticleYear
The serotonin connection in OCD. Comments on "Recent advances in obsessive-compulsive disorder".
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1991, Volume: 5, Issue:1

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Dogs; Obsessive-Compulsive Disorder; Piperazines;

1991